Janelle Goulard

Investment Stage

Focus Areas

About Investor

Janelle Goulard is a Partner at Pangaea Ventures, a hard-tech and impact-focused venture firm, focusing on healthcare and agriculture investments. She typically writes $3.0M-$8.0M checks into Series A and Series B rounds in sectors like AgTech, climate and cleantech, biotech, medical devices and advanced materials, with a stated emphasis on impact and backing diverse and female founders. She serves as Investor at Aspect Biosystems, Board Member at Sun Genomics and Biodel AG, and Board Observer at Kanvas Biosciences, and previously served as Board Director at Modulim (2019-2023). Her background spans more than a decade in healthcare, including strategic and operations roles at GE Healthcare in Europe and the US and launching a population health technology platform that became a joint venture between GE and Microsoft. She holds an MBA in Entrepreneurship and Innovation from the University of British Columbia and a BComm from McGill University. She is based in Scottsdale, Arizona.